Objective: The objective of this study was to determine magnetic resonance imaging (MRI)-related heating for a low-intensity focused ultrasound pulsation (LIFUP) device used during MRI performed at 3 T/128 MHz.
INTRODUCTION
Low-intensity focused ultrasound pulsation (LIFUP) is a promising new technique for noninvasive neuromodulation (1) . LIFUP utilizes low-energy ultrasound (US) waves that pass through the skin and skull without surgery and which can be focused almost anywhere in the brain to modulate neural activity (2) . LIFUP neuromodulation has the potential to treat a wide range of neurologic and psychiatric conditions, including epilepsy, obsessive-compulsive disorder, and depression (3) (4) (5) .
Currently, therapeutic devices for neuromodulation in the brain suffer from several limitations, including invasiveness and lack of spatial specificity. For example, deep brain stimulation (DBS) has the advantages of being highly focused and of being able to target structures deep in the brain, but it requires invasive surgery (e.g., (6) (7) (8) ). Vagus nerve stimulation, while not involving penetration through the skull, still requires surgery and does not have high spatial specificity (9) . By contrast, repetitive transcranial magnetic stimulation has the benefit of being noninvasive but has severely limited spatial resolution, particularly at depths below superficial cortex (10) . Similarly, cranial electrotherapy stimulation and transcranial direct current stimulation, while also noninvasive, lack spatial specificity (11) .
In contrast to currently approved technologies, LIFUP has the potential for noninvasive, yet highly targeted, neuromodulation. Multiple investigations have demonstrated neuromodulation with LIFUP in multiple animal models. Early demonstrations of low-intensity focused US neuromodulation include stimulation of auditory nerve responses in cats (12) . Another study showed that low-intensity continuous wave US could enhance nerve conduction in frogs (13) . More recently, one group showed LIFUP capable of exciting neuronal circuits in mice, initially in excised brains (14) and then in live animals (15) . Transcranial modulation of the hypothalamus also has been demonstrated in a mini-pig (2), the lower plate of the skull of which is very similar in thickness to the human temporal bone. Further research showed that the effects of LIFUP depend on US pulsing parameters (16) . These experiments demonstrated that LIFUP is capable of either stimulating or suppressing regional cortical activity in rabbits in vivo. Most importantly for potential clinical applications, recent studies in rats demonstrate the remarkable result that LIFUP can reduce the duration and severity of seizures in both acute and chronic models of epilepsy (3, 17) .
Despite the therapeutic efficacy in animal models, the mechanism of LIFUP neuromodulation is not well characterized. It likely has an effect through mechanical interaction with neurons (18) , and some speculate that this occurs via microtubules (19, 20) . And while the neuromodulatory effects of LIFUP have been demonstrated clearly in multiple animal models, it has not yet been tested in humans. LIFUP appears safe enough for human applications, as prior animal studies have examined sonicated tissue for evidence of ischemia, apoptosis, necrosis, and blood-brain barrier disruption and have not observed any noticeable tissue damage (14) (15) (16) . This is not surprising given that LIFUP is effective even at intensities within the range of diagnostic US imaging (3, 14, 15) . In consideration of the safety record of LIFUP in animal testing, once a suitable LIFUP device can be developed for human applications, human trials are warranted.
However, there are several challenges and possible safety concerns that must be addressed for this technique to be made ready for use in human subjects. First, for accurate targeting of LIFUP sonication, it is a practical necessity to use concurrent neuroimaging, such as that provided by magnetic resonance imaging (MRI). MRI is vital to positioning the transducer accurately, as the transducer can be moved in three dimensions. Functional MRI may also be used to visualize the effects of LIFUP on brain activity. Notably, the safety profile of a LIFUP device while utilized on a patient undergoing an MRI procedure has not yet been reported. MRI-related heating that may occur in association with the use of this equipment is a potential safety concern. The intent, in the present project, was to evaluate the MRI-related heating issues for a LIFUP device (BXPulsar 1001, Brainsonix, Inc., Los Angeles, CA, USA) by measuring heating of a skull sample during MRI.
Because the skull does not transmit US easily, another potential hazard is excessive heating caused by US absorption in the skull during sonication. Due to its limited aperture, this risk is increased in the case of a single-element transducer (21) . Furthermore, while functional MRI scans that could be used concurrently with LIFUP have inherently low specific absorption rate (SAR), MR-related heating would be additive to US-related heating. Thus, we assessed heating of the skull sample during concurrent MRI with moderate SAR and LIFUP sonication as well.
MATERIALS AND METHODS

Phantom
MRI-related heating was assessed with a single-element transducer system (BXPulsar 1001, Brainsonix, Inc.) using an agarsubstitute phantom prepared to simulate human brain tissue according to King et al. (22) . This phantom was selected to simulate human brain tissue in thermal properties (at 20°C thermal conductivity = 0.55W/mC, diffusivity = 0.11 mm dB/cm, speed of sound = 1579 m/sec). Tissue-mimicking phantoms are used commonly for safety assessment of medical devices in MR environments, and this experimental setup was chosen in consideration of methodology described in previous reports (23) (24) (25) (26) .
The phantom was created by mixing and heating calcium chloride (4 g), potassium sorbate (1 g), gellan gum powder (15 g), aluminum oxide powder (13.5 g), 1-propanol (120 mL), and degassed water (1 L), resulting in a hot gel. Approximately 980 mL of gel was allowed to equilibrate to room temperature in a 1.1 L plastic container. Once it cooled and solidified, a piece of human temporal bone (90 mm ¥ 90 mm, Skulls Unlimited, Oklahoma City, OK, USA) was placed on top of the phantom and within the container (Fig. 1) . To reduce the space between the skull sample and the phantom material, the skull sample was pressed gently into the phantom material. The rest of the container was then filled with a 0.9% saline solution. Because this phantom and experimental setup lack blood flow, this simulates an extreme condition used to assess MRI-related heating.
US System
The system consisted of an air-backed, spherical-segment focused US transducer (diameter = 6.1 cm; radius of curvature = 6.1 cm) operating at a fundamental frequency of 650 kHz (custom made by the University of Southern California Resource Center for Medical Ultrasonic Transducer Technology). The shape of the transducer resulted in a US beam that was focused at a distance equal to the radius of curvature. The transducer was controlled with a sinusoidal electrical signal from a function generator (Agilent Technology, Santa Clara, CA, USA), which was amplified by a linear radiofrequency (RF) amplifier (240L; ENI Inc., Rochester, NY, USA). The transducer was located in a plastic housing (Custom Stamping Inc., Carson City, NV, USA). The housing was filled with degassed, deionized water and enclosed with a polyethylene membrane permeable 
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to US. The plastic housing contained an axial adjustment, which could raise and lower the transducer. In order to achieve the greatest potential for skull heating, the transducer was adjusted to maximal displacement from the skull, approximately 8 mm.
Temperature Measurements
Temperature measurements were obtained using a fluoroptic thermometry system (Model 3100, LumaSense Technologies, Santa Clara, CA, USA) with a laptop recording measurements every 5 sec. Fluoroptic thermometry probes (diameter 0.5 mm) were positioned on the skull to record temperatures during the heating assessment, as follows ( Probes 2 and 3, being on top of the skull, were pressed between the skull and the membrane of the transducer holder. Probes 1 and 4, being beneath the skull, were pressed between the skull and the phantom. The positions for the thermometry probes were selected to study representative areas that would likely exhibit the highest temperatures during MRI-related and US-related heating scenarios. Probes were affixed to the surface of the skull with paper tape (3M Company, Minneapolis, MN, USA) known to be permeable to fluid and noninsulating. The probes were applied before the skull was submerged in saline as illustrated in Figure 2 . The transducer, inside the holder, was placed at the midline of the phantom. The phantom was placed at the midline of the receive-only RF head coil (Fig. 3) . The positions of the thermometry probes were inspected and verified immediately before and after the MRI-related heating assessment.
MRI and US Conditions
MRI was performed at 3 T/128 MHz (Siemens Medical, MAGNE-TOM Trio, software version VB17A, Erlangen, Germany) using a 12-channel receive-only RF head coil. MRI parameters were selected to utilize RF energy at either a medium (T2SPACE; TR = 3200; TE = 213; ETL = 141; slices = 15) or high level (Turbo Spin Echo; TR = 6100; TE = 79; ETL = 21; slices = 25) (27) . A nominal weight of 120 lb was entered into the system. For the medium scan level, the MR system reported a whole-body average specific absorption rate (SAR) of 0.4 W/kg and a head average SAR of 1.1 W/kg. For the high-SAR scan, the MR system reported a whole-body average SAR of 0.7 W/kg and a head average SAR of 2.0 W/kg.
Two high-SAR scans were performed with no LIFUP sonication. Two medium-SAR scans were performed with LIFUP at the following parameters: pulse width = 0.5 msec, pulse repetition frequency = 100 Hz, derated spatial-peak temporal-average intensity (I spta) = 3870m W/cm 2 , and spatial-peak pulse-average intensity (Isppa) = 77.4 W/cm 2 . US intensities were derated from values measured in a water tank using an Onda HGL-1000 hydrophone (Onda Corp, Sunnyvale, CA, USA). 
RESULTS
The temperature-recording results are summarized in Table 1 . These findings indicated that MRI-related heating in the high-SAR scan, without US applied, was very mild (Յ0.6°C). In the medium-SAR scan, with LIFUP at a derated intensity of 3870 mW/cm 2 , heating was substantially higher, though not at a level that would be dangerous for a human subject (Fig. 4) . Temperature increase during LIFUP application in our experimental setup began rapidly but reached a plateau after approximately 7 min of continuous stimulation. The observed temperature decreases after LIFUP cessation was approximately symmetrical to the rate of increase. Quantitatively, this approximated an exponential time course fitted closely by the function where q indicates temperature, q0 is the final equilibrium temperature, and k is a time constant. Both q0 and k differed between probe locations (Table 2) . These data and the small residual fitting errors suggest that only uncomplicated first-order temperature kinetics are needed for accurate modeling of final tissue temperature in essentially arbitrary patterns of LIFUP application. Because LIFUP in clinical use will be limited to under 30 sec per sonication application, the maximal heating over the first 30 sec is shown in Table 3 . Both the experimental data and the model indicate maximum temperature increases of less than 1°C.
DISCUSSION
The highest temperature increase recorded for the LIFUP device during MRI performed at a relatively high, head-averaged SAR (2.0 W/kg) was 0.6°C. This slight temperature change is not a safety concern for human subjects. This finding is not surprising given that the transducer and holder contain no metal other than the insulated input cable and a small amount of solder. In addition, no metal touches the phantom (nor will metal be in contact with the patient during the intended use of this device). Therefore, MRI-related heating is not of concern for this particular device.
Under the MRI conditions used in this evaluation, the findings indicated that the LIFUP device is safe from a thermal perspective, as evidenced by minimal heating, even at high SAR level. Typical clinical procedures performed at 3 T/128 MHz use even lower SAR levels, and thus, MRI-related heating will be even less.
Not surprisingly, given that the skull is known to absorb US, greater heating was observed during LIFUP sonication. The heating was quite moderate, with a maximum temperature change at any thermometry probe of only 3.1°C. However, this was observed only after more than 8 min of continual use. Importantly, therapeutic LIFUP is intended for only brief applications (e.g., under 30 sec). Heating in the short term was dramatically lower than heating over several minutes. Over the course of the first 30 sec, the greatest temperature rise observed at any thermometry probe was still below 1°C. Obviously, lower intensities of LIFUP have even lower risk of heating.
The heating behavior was consistent with the deposition of constant heat energy into a thermal reservoir of fixed capacity and constant cooling rate. The amount of heating and time course varied by the location of each thermometry probe. This is likely due to numerous factors including variability of skull thickness and the angle of the skull relative to the US transducer, which can affect US absorption. In addition, there may also have been additional artifactual heating caused by tiny air bubbles trapped by the skull or tape; these have the potential to increase US heating. In the clinical setting, air bubbles will not be present, as LIFUP will be applied The maximum temperature change from baseline is listed for each temperature probe in each of the four scans. MRI, magnetic resonance imaging; SAR, specific absorption rate; US, ultrasound. ), where q indicates temperature, q0 is the final equilibrium temperature, and k is a time constant.
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through the unopened skin and skull. Furthermore, several studies have shown that, owing to perfusion, US heating is lower in live tissue than cadaveric tissue by 25-43% (28, 29) . Given the use of a static phantom material, which lacks perfusion, it can be presumed that in vivo human applications present an even lower risk of heating. This experimental setup, therefore, represents a worst-case scenario.
Tissue safety during temperature increases is related to both the magnitude and duration of the applied heat (30, 31) . The clinically accepted time of safe exposure to temperature increases is described by the equation Ts = 4 6-t , where Ts is the length of time, in minutes, of safe heating and t is steady-state temperature change. The equation states that an increase of 3°C, for example, is safe for a 64-min period of application. In the experiments performed in this investigation, temperature increases on the interior surface of the skull stayed below 1°C for the first 30 sec. Therefore, LIFUP used for periods shorter than 30 sec is unlikely to cause any thermal damage.
The safety of the LIFUP device relative to the concomitant use of MRI, especially when performed at 3 T/128 MHz, is crucial for applications to human subjects. Because the US beam may be deflected by the skull, concurrent use of LIFUP and MRI is a practical necessity to determine whether LIFUP sonication is reaching and/or affecting the target brain region. In the future, it may be possible to use MRI only in an initial examination for LIFUP targeting and, once targeting parameters have been determined, perform subsequent LIFUP procedures without an MRI.
LIFUP presents the possibility of the same neuromodulatory capabilities as DBS, but without surgery. DBS has shown promise in the treatment of numerous disorders, including chronic pain, epilepsy, obsessive-compulsive disorder, depression, obesity, and many other applications (4, 5, 32, 33) . Thus, all these disorders are potential treatment targets for LIFUP. Therapy with LIFUP may be most appropriate when medical treatments alone are not adequate and when invasive strategies (i.e., ablation and DBS) are not appropriate. An added advantage of LIFUP is that, by coupling it with fMRI, malfunctioning neuronal circuits participating in the pathophysiology of these illnesses could potentially be correctly identified and probed prior to treatment.
No discussion of LIFUP would be complete without contrasting it with magnetic resonance guided high-intensity focused US (MRg-HIFU), which is currently being used in human trials for a variety of clinical applications, including neuropathic pain (34) and essential tremor (35) . There are several differences between MRg-HIFU and LIFUP that provide insight into the safety profile of LIFUP. Most importantly, MRg-HIFU uses very high-intensity continuous US to heat tissue, generally more than ten times the intensities used here and often much greater. In contrast, LIFUP uses low-intensity US in a pulsed manner, which greatly reduces the likelihood of heating in the tissue. The main source of risk for LIFUP comes from the limited aperture of a single-element transducer, which increases the risk of skull heating. Addressing this risk is one of the primary reasons we performed this study. Lastly, phased arrays in MRg-HIFU allow for shaping of the US focus, which can be distorted and displaced by the skull. A single-element transducer presents a challenge in creating a well-defined focus through the skull. LIFUP is therefore confined mostly to targets beneath the thin temporal window. However, by using a low frequency and by targeting through the thin temporal bone, even a single-element transducer can result in a well-formed focus (36) .
LIMITATIONS
While these results indicate that concurrent use of LIFUP and MRI will not cause excessive heating of the skull, this is not a definitive test of LIFUP safety. In addition to skull heating, US has the potential also to heat brain tissue. However, the methods used in this paper do not address this issue.
It is possible that higher temperature increases occurred not on the surface of the skull, but within the bone itself. However, physical and practical limitations prevent placement of temperature probes within the thin temporal bone to make accurate, nonartifactual measurements. Furthermore, as the heat does not have very far to diffuse to the surface, the temperature probes would still be able to detect its effects.
CONCLUSIONS
Importantly, the findings reported herein are highly specific to the MRI conditions that were used in our investigation. MRI-related heating will require further characterization if a different static magnetic field strength/RF frequency is used and/or if a transmit/receive head coil is utilized for the MRI examination. Given that it creates only mild heating of the skull during typical clinical use conditions, LIFUP appears to be safe for applications in human subjects with concurrent MRI performed at 3 T/128 MHz. Therefore, we propose to initiate first-in-human trials of LIFUP in the near future.
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